中國移動(600941.SH)再創新高!上市時曾遭棄購7.56億元創記錄
格隆匯10月12日丨中國移動近日逆勢走強,屢創上市新高,今日盤中一度漲超2%至72.5元,為今年1月上市以來的最高價。中國移動於今年1月5日在A股掛牌上市,募資總額486.95億元拿下A股近10年最大IPO,當時IPO價格57.58元還“嚇退”不少投資者,棄購金額達7.56億元也創下了記錄。但上市以來截至今日盤中創出的最高價72.5元,中國移動目前股價較發行價累計上漲25.91%。財報數據顯示,上半年中國移動營收、淨利潤分別為4969.34億元、703億元,增速分別達到12.01%、18.9%,不論營收還是淨利潤均居於三大運營商首位,且高出其他二者數倍。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.